Epstein Secrets

ion's military, internal security, government-controlled news media, and intelligence services." In addition, intelligence officials "in the US and Western Europe say, Russia's foreign and military intelligence agencies have," in the words of one European official, "thoroughly penetrated or intimidated their c

simple, cheap and fast coronavirus test just approved by the FDA and is being hailed as a game changer." CBS' Manuel Bojorquez added, "The FDA gave Abbott's $5 antigen test emergency approval and results in 15 minutes could help screen who could board a plane or enter a classroom. But antigen tests ar

ion's military, internal security, government-controlled news media, and intelligence services." In addition, intelligence officials "in the US and Western Europe say, Russia's foreign and military intelligence agencies have," in the words of one European official, "thoroughly penetrated or intimidated their

simple, cheap and fast coronavirus test just approved by the FDA and is being hailed as a game changer." CBS' Manuel Bojorquez added, "The FDA gave Abbott's $5 antigen test emergency approval and results in 15 minutes could help screen who could board a plane or enter a classroom. But antigen tests ar

ion's military, internal security, government-controlled news media, and intelligence services." In addition, intelligence officials "in the US and Western Europe say, Russia's foreign and military intelligence agencies have," in the words of one European official, "thoroughly penetrated or intimidated their

simple, cheap and fast coronavirus test just approved by the FDA and is being hailed as a game changer." CBS' Manuel Bojorquez added, "The FDA gave Abbott's $5 antigen test emergency approval and results in 15 minutes could help screen who could board a plane or enter a classroom. But antigen tests ar

s & Infrastructure. Investments will be predominantly in the U.S., but could include a small number of investments in other parts of the world (e.g., Western Europe or Canada). The focus within each sector will be the following: Biopharmaceuticals: As in NLV-I and NLV-II, biopharmaceutical investments will be th

She was previously on the boards of directors of Interlace (NLV-I company acquired by Hologic), Epicor (acquired by St. Jude), Visiogen (acquired by Abbott), PercuSurge (acquired by Medtronic), and NxStage Medical (NASDAQ: NXTM). Prior to joining the healthcare investment team at Sprout, Jeani was a Gene